228 related articles for article (PubMed ID: 8081708)
1. Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC).
Szczepek B; Szymańska D; Decker E; Wasowska H; Slupek A; Rowińska-Zakrzewska E
Lung Cancer; 1994 Jul; 11(1-2):93-104. PubMed ID: 8081708
[TBL] [Abstract][Full Text] [Related]
2. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years.
Johnson BE; Linnoila RI; Williams JP; Venzon DJ; Okunieff P; Anderson GB; Richardson GE
J Clin Oncol; 1995 Jan; 13(1):101-11. PubMed ID: 7799009
[TBL] [Abstract][Full Text] [Related]
3. Relapse of stage I small cell lung cancer ten or more years after the start of treatment.
Matsui K; Sawa T; Suzuki H; Nakagawa K; Okamoto N; Tada T; Nagano T; Masuda N
Jpn J Clin Oncol; 2006 Jul; 36(7):457-61. PubMed ID: 16782728
[TBL] [Abstract][Full Text] [Related]
4. Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.
Arriagada R; Kramar A; Le Chevalier T; De Cremoux H
J Clin Oncol; 1992 Mar; 10(3):447-51. PubMed ID: 1311025
[TBL] [Abstract][Full Text] [Related]
5. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
[TBL] [Abstract][Full Text] [Related]
6. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Yue X; Zang QC
Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
[TBL] [Abstract][Full Text] [Related]
7. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
9. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
[TBL] [Abstract][Full Text] [Related]
10. [Double cancer in small cell lung cancer patients treated with intensive chemotherapy with or without radiation therapy].
Segawa Y; Ohnoshi T; Ueoka H; Miyake K; Takigawa N; Kimura I; Hiraki S; Fujii M; Machida K; Moritaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Nov; 29(11):1432-8. PubMed ID: 1663179
[TBL] [Abstract][Full Text] [Related]
11. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
12. Late recurrence of small-cell lung cancer: treatment and outcome.
Sekine I; Nishiwaki Y; Kakinuma R; Kubota K; Hojo F; Matsumoto T; Ohmatsu H; Yokozaki M; Goto K; Kodama T
Oncology; 1996; 53(4):318-21. PubMed ID: 8692537
[TBL] [Abstract][Full Text] [Related]
13. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].
Remiszewski P; Roszkowski-Sliz K; Wiatr E; Roszkowska-Sliz B; Zych J; Kurzyna M; Jodkiewicz Z; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 2003; 71(3-4):139-47. PubMed ID: 14587419
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
Alshehadat S; Sahmoun AE
Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
[TBL] [Abstract][Full Text] [Related]
16. [Second primary cancers after small-cell lung cancer].
Soria JC; Bréchot JM; Lebeau B; Rochemaure J
Bull Cancer; 1997 Aug; 84(8):800-6. PubMed ID: 9339185
[TBL] [Abstract][Full Text] [Related]
17. Long term survival of small cell lung cancer patients after chemotherapy.
van der Gaast A; Postmus PE; Burghouts J; van Bolhuis C; Stam J; Splinter TA
Br J Cancer; 1993 Apr; 67(4):822-4. PubMed ID: 8385981
[TBL] [Abstract][Full Text] [Related]
18. Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer.
Chute JP; Kelley MJ; Venzon D; Williams J; Roberts A; Johnson BE
Chest; 1996 Jul; 110(1):165-71. PubMed ID: 8681622
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-up.
Fukuoka M; Masuda N; Matsui K; Makise Y; Takada M; Negoro S; Sakai N; Kusunoki Y; Kudoh S; Ryu S
Cancer; 1990 Apr; 65(8):1678-84. PubMed ID: 2156596
[TBL] [Abstract][Full Text] [Related]
20. Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
Arriagada R; Le Chevalier T; Ruffié P; Chomy P; de Cremoux H
Lung Cancer; 1994 Mar; 10 Suppl 1():S289-98. PubMed ID: 8087522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
